دورية أكاديمية

Off-label use of intravitreal bevacizumab: A global conundrum

التفاصيل البيبلوغرافية
العنوان: Off-label use of intravitreal bevacizumab: A global conundrum
المؤلفون: Samya Singh, Sandeep Saxena, Levent Akduman, Carsten H Meyer
المصدر: Indian Journal of Ophthalmology, Vol 72, Iss 5, Pp 617-619 (2024)
بيانات النشر: Wolters Kluwer Medknow Publications, 2024.
سنة النشر: 2024
المجموعة: LCC:Ophthalmology
مصطلحات موضوعية: age related macular degeneration, bevacizumab, diabetes macular edema, intravitreal injection, off-label use, Ophthalmology, RE1-994
الوصف: Bevacizumab is a monoclonal, humanized, full-length antibody targeting vascular endothelial growth factor(VEGF-A), known for its anti-angiogenic properties. The off-label use of bevacizumab has stirred legal, financial, industrial, and ethical complexities. With its potential to treat diverse ocular conditions, this commentary delves into the multifaceted dimensions of bevacizumab’s off-label utilization, encompassing clinical trials, regulatory frameworks, safety considerations, comparative effectiveness, and economic implications.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0301-4738
1998-3689
العلاقة: https://journals.lww.com/10.4103/IJO.IJO_2166_23Test; https://doaj.org/toc/0301-4738Test; https://doaj.org/toc/1998-3689Test
DOI: 10.4103/IJO.IJO_2166_23
الوصول الحر: https://doaj.org/article/da6e9047fe3c4c7c82af5dc2f4b1466dTest
رقم الانضمام: edsdoj.6e9047fe3c4c7c82af5dc2f4b1466d
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:03014738
19983689
DOI:10.4103/IJO.IJO_2166_23